For the year ending 2025-12-31, CRMD has $826,142K in assets. $420,835K in debts. $144,837K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 144,837 | |||
| Short-term investments | 3,694 | |||
| Account receivables, net | 171,233 | |||
| Inventories | 29,716 | |||
| Prepaid expenses and other current assets (including restricted cash of 656 and 0 at december 31, 2025, and december 31, 2024) | 17,571 | |||
| Total current assets | 367,051 | |||
| Property and equipment, net | 5,959 | |||
| Other long-term assets (including restricted cash of 332 and 105 at december 31, 2025, and december 31, 2024, net of current) | 23,816 | |||
| Goodwill | 30,002 | |||
| Intangible asset, net | 379,072 | |||
| Deferred tax assets | 16,276 | |||
| Operating lease right-of-use assets, net | 3,020 | |||
| Finance lease- right-of-use assets, net | 946 | |||
| Total assets | 826,142 | |||
| Accounts payable | 7,884 | |||
| Accrued expenses | 161,921 | |||
| Contingent consideration, short-term | 3,015 | |||
| Operating lease liabilities, short-term | 853 | |||
| Financing lease liability, short-term | 596 | |||
| Total current liabilities | 174,269 | |||
| Convertible senior notes, net of deferred financing costs | 144,626 | |||
| Contingent consideration, net of current portion | 99,101 | |||
| Operating lease liabilities, net of current | 2,253 | |||
| Finance lease liabilities, net of current | 586 | |||
| Total liabilities | 420,835 | |||
| Common stock - 0.001 par value 160,000,000 shares authorized at december 31, 2025 and 2024 79,260,667 and 64,411,295 shares issued and outstanding at december 31, 2025 and 2024, respectively | 79 | |||
| Accumulated other comprehensive gain | 3 | |||
| Additional paid-in capital | 581,800 | |||
| Accumulated deficit | -176,575 | |||
| Total stockholders equity | 405,307 | |||
| Total liabilities and stockholders equity | 826,142 | |||
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)